Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

NCT02426359 is registered in ClinicalTrials.gov with Qurient Co., Ltd. as lead sponsor.

NCT NCT02426359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02426359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Lead sponsor
Qurient Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
May 31, 2016
Enrollment
57 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe atopic dermatitis